JVC Investment Partners is a private investment firm that partners with owners and managers of middle-market companies by investing its own capital. The firm focuses on low middle-market and growth platforms, primarily in the healthcare industry, across direct private equity, growth equity, and venture capital.
30% of their portfolio is in Healthcare. Their most common stage is series-a (50% of deals). Average disclosed round size is $92.0M (across 7 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Magenta Medical | Growth | $105M | Jul 2024 |
 Magenta Medical | Unknown | $105M | Jan 2023 |
| NNewAmsterdam Pharma | Series A | — | Jan 2021 |
| IImmPACT Bio USA | Series A | $18M | Aug 2020 |
 ImmPACT Bio | Series A | — | Aug 2020 |
| AArcellx, Inc. | Series B | $85M | Oct 2019 |
| Magenta Medical | Unknown | $105M | Jul 2019 |
| PPharma Two B Ltd. | Series C | $30M | Feb 2017 |
 New Amsterdam Pharma | Series A | $196M | — |
| NNewAmsterdam | Series A | — | — |
Top Co-Investors
OrbiMed5 shared
Viking Global Investors4 shared
New Enterprise Associates3 shared
RA Capital Management3 shared
BVF Partners L.P.3 shared
LSP Dementia Fund3 shared
Forbion3 shared
Morningside3 shared
Presight Capital3 shared
ALIVE2 shared
Novo Holdings A/S2 shared
Takeda Ventures, Inc.2 shared
XYZ Venture Capital1 shared
Novo Capital1 shared
aMoon1 shared
Novartis Pharma AG1 shared
AJU IB Investment1 shared
LG Technology Ventures1 shared
Frazier Healthcare Partners1 shared
venBio1 shared
Last updated: 7 October 2026